Lilly 3977 40 mg Pill - gray capsule/oblong, 18mm
Generic Name: selpercatinib
Pill with imprint Lilly 3977 40 mg is Gray, Capsule/Oblong and has been identified as Retevmo 40 mg. It is supplied by Eli Lilly and Company.
Retevmo is used in the treatment of Non-Small Cell Lung Cancer; Solid Tumors; Thyroid Cancer and belongs to the drug class multikinase inhibitors. Retevmo 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Lilly 3977 40 mg
Retevmo
- Generic Name
- selpercatinib
- Imprint
- Lilly 3977 40 mg
- Strength
- 40 mg
- Color
- Gray
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eli Lilly and Company
- National Drug Code (NDC)
- 00002-3977
More about Retevmo (selpercatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
